Changes of cartilage and bone markers after intraarticular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 64, Issue 12, 2005, Pages 1750-1753

  Weitoft, Tomas ^a   Larsson, A ^b   Saxne, T ^c   Ronnblom L ^b  

^a GÄVLE HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; DEOXYPYRIDINOLINE; GLUCOCORTICOID; OSTEOCALCIN; TRIAMCINOLONE HEXACETONIDE;

ADULT; AGED; ARTICLE; BED REST; BLOOD ANALYSIS; BONE METABOLISM; CARTILAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFECT; HUMAN; JOINT MOBILITY; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SYNOVITIS; URINALYSIS;

ADULT; AGED; AMINO ACIDS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BED REST; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; CARTILAGE, ARTICULAR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLUCOCORTICOIDS; GLYCOPROTEINS; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOGENESIS; SYNOVITIS; TRIAMCINOLONE ACETONIDE;

EID: 27944490312     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.035022     Document Type: Article

References (27)

1. Topp JR, Cross EG, Fam AG. Treatment of persistent knee effusions with intraarticular radioactive gold. Can Med Assoc J 1975;112:1085-9.
2. Oka M. Radiation synovectomy of the rheumatoid knee with yttrium 90. Ann Clin Res 1975;7:205.
3. Chakravarty K, Pharoah PD, Scott DG. A randomized controlled study of postinjection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol 1994;33:464-8.
4. Neustadt DH. Synovitis of the knee. Effects of postinjection rest. Clin Rheumatol Prod 1985;3:65-8.
5. Behrens F, Shepard N, Mitcell N. Alteration of rabbit articular cartilage of intra-articular injections of glucocorticoids. J Bone Surg 1975;57A:70-6.
6. Gogia P, Brown M, Al-Obaidi S. Hydrocortisone and exercise effects on articular cartilage in rats. Arch Phys Med Rehabil 1993;74:463-6.
7. Gibson T, Burry HC, Poswillo D, Glass J. Effect of intra-articular corticosteroid injections on primate cartilage. Ann Rheum Dis 1976;36:74-9.
8. Pelletier J-P, Martel-Pelletier J. Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1989;32:181-93.
9. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;20:142-0.
10. Saxne T, Heinegard D, Wollheim F. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into synovial fluid. Ann Rheum Dis 1986;45:491-7.
11. Saxne T, Mansson B. Molecular markers for assessment of cartilage damage in rheumatoid arthritis. In: Firestein GS, Panayi GS, Wollheim FA, eds. Rheumatoid arthritis: new frontiers in pathogenesis and treatment. Oxford: Oxford University Press, 2000:291-304.
12. Gamero P, Rousseau JC, Delmas PD. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-68.
13. Saxne T, Heinegard D. Cartilage oligomeric protein a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
14. Amett FC, Edworthy SM, Bloch DA, Shane DA, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Steinbrocker O, Traeger CH, Betterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
16. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:263-71.
17. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Pulte LB, van Riel PL. Modified disease activity scores that include twenty-eight joint counts. Development of and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
18. Larsen A, Dale K. Standardized radiological examination of rheumatoid arthritis in therapeutical trials. In: Dumonde DC, Jasani MK, eds. The recognition of antirheumatic drugs. Lancaster: MTP Press, 1978:285-92.
19. Vingsbo-Lundberg C, Saxne T. Increased serum levels of COMP in chronic erosive arthritis in rats. Arthritis Rheum 1998;41:544-50.
20. Joosten L, Helse MM, Saxne T, van der Loo, Heinegard D, van den Bergh W. IL-1 αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-55.
21. Larsson E, Erlandsson-Harris H, Klareskog L, Larsson A, Mansson B, Saxne T. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology 2004;180:62-5.
22. Crnkic M, Mansson B, Larsson L, Geborek P, Heinegard D, Saxne T. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 2003;5:181-5.
23. Emkey RD, Lindsay R, Lyssy J, Weisberg JS, Dempster DW, Shen V. Systemic effect of intra-articular administration or corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:277-82.
24. Sharif M, Salisbury C, Taylor DJ, Kirwan JR. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum 1998;41:1203-9.
25. Heart S, Eastell R. Biochemical markers of bone turnover. Curr Opin Nephrol Hypertens 1999;8:421-7.
26. Lems WF, Gerritz MI, Jacobs JWG, van Vugt RM, van Rijn HJ, Bijlsma JW. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:288-93.
27. Frediani B, Falsetti P, Bisoqno S, Baldi F, Acciai C, Filippou G, et al. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomised and controlled study. J Rheumatol 2004;31:1083-7.